SightfileU.S. market data from official filings

NEOGEN CORPORATION (NEOG)

Name: NEOGEN CORPORATION (NEOG) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000711377 · EDGAR filings · Updated 2026-07-07

NEOGEN CORPORATION (NEOG) has reported institutional ownership of 107.0%, with 308 institutional managers holding positions valued at $2.16B per the latest 13F reporting period.

Institutional ownership

107.0%

Institutional managers

308

Reported 13F value

$2.16B

Insider activity

92 trans.

$774.9K net buying

Latest updates

2026-07-07 — SCHEDULE 13G filed
2026-06-25 — 11-K filed
2026-06-04 — Insider transaction reported (Form 4)
2026-06-03 — Notice of proposed sale filed (Form 144)
2026-05-29 — Notice of proposed sale filed (Form 144)
2026-05-20 — SD filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, NEOGEN CORPORATION has 308 institutional holders and institutional ownership of 107.0%.

Insider activity

Insiders reported 92 transactions (15 buys, 0 sells) across 19 reporting insiders, with a net reported value of $774.9K.

Related companies

KODIAK SCIENCES (KOD) · ALUMIS INC (ALMS) · KINIKSA PHARMACEUTICALS INTL (KNSA) · AGIOS PHARMACEUTICALS INC (AGIO) · ADAPTIVE BIOTECHNOLOGIES COR (ADPT) · ULTRAGENYX PHARMACEUTICAL IN (RARE)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-07.